(Unlearned) lessons from John Graunt and Kenneth Rothman: A "CLASSic" example

Збережено в:

Бібліографічні деталі
Опубліковано в::	Clinical Therapeutics vol. 25, no. 11 (Nov 2003), p. 2891
Автор:	Arellano, Felix M.
Співавтор:	Class
Інші автори:	Castellsague, Jordi
Опубліковано:	Elsevier Limited
Предмети:	Anti-Inflammatory Agents, Non-Steroidal > adverse effects Data Interpretation, Statistical Endpoint Determination Epidemiologic Methods Epidemiologic Research Design Humans Peptic Ulcer > chemically induced Randomized Controlled Trials as Topic
Онлайн доступ:	Citation/Abstract Full Text Full Text - PDF
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Опис
Короткий огляд:	This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Lonngterm Arthritis Safety Study. This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Long-term Arthritis Safety Study.
ISSN:	0149-2918 1879-114X
DOI:	10.1016/S0149-2918(03)80341-7
Джерело:	Healthcare Administration Database